These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 524947)

  • 41. Simplified test for determination of drug-oxidizing capacity in rats with chemical-induced liver injury using caffeine and trimethadione as model drugs.
    Tanaka E; Ishikawa A; Misawa S
    Pharmacol Toxicol; 1992 Mar; 70(3):177-80. PubMed ID: 1579543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and properties of galactokinase from pig liver.
    Ballard FJ
    Biochem J; 1966 Jan; 98(1):347-52. PubMed ID: 5938660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and pharmacodynamics of naproxen in acute experimental hepatitis.
    Favari L; Castañeda-Hernández G; Hoyo-Vadillo C
    Arzneimittelforschung; 1993 Jun; 43(6):675-9. PubMed ID: 8352821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in polyamine metabolism of rat liver after administration of D-galactosamine. Favorable effects of putrescine administration on galactosamine-induced hepatic injury.
    Daikuhara Y; Tamada F; Takigawa M; Takeda Y; Mori Y
    Gastroenterology; 1979 Jul; 77(1):123-32. PubMed ID: 447009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatic galactose metabolism quantified in humans using 2-18F-fluoro-2-deoxy-D-galactose PET/CT.
    Sørensen M; Mikkelsen KS; Frisch K; Bass L; Bibby BM; Keiding S
    J Nucl Med; 2011 Oct; 52(10):1566-72. PubMed ID: 21875925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impaired ganglioside synthesis in rat liver after D-galactosamine administration in vivo.
    Rupprecht E; Hans C; Leonard G; Decker K
    Biochim Biophys Acta; 1976 Oct; 450(1):45-56. PubMed ID: 974155
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of the hepatotoxic effects of D-galactosamine by D-galactose.
    Mészáros K; Antoni F; Hrabák A; Szikla C; Garzó T; Tompa A; Lapis K
    FEBS Lett; 1973 Sep; 35(1):1-3. PubMed ID: 4751995
    [No Abstract]   [Full Text] [Related]  

  • 48. [Studies on the mechanism of galactosamine-induced hepatitis].
    Keppler D; Reutter W; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():361-3. PubMed ID: 5400153
    [No Abstract]   [Full Text] [Related]  

  • 49. [Primary and secondary liver response to D-galactosamine administration in galactosamine hepatitis].
    Reutter W; Bauer C; Bachman W; Lesch R
    Verh Dtsch Ges Inn Med; 1973; 79():927-30. PubMed ID: 4790045
    [No Abstract]   [Full Text] [Related]  

  • 50. Bile duct obstruction is not a prerequisite for type I biliary epithelial cell hyperplasia.
    Kossor DC; Meunier PC; Dulik DM; Leonard TB; Goldstein RS
    Toxicol Appl Pharmacol; 1998 Oct; 152(2):327-38. PubMed ID: 9853002
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [AFP producing cells during liver restitution after acute galactosamine hepatitis in the rat (author's transl)].
    Noguchi T
    Nihon Shokakibyo Gakkai Zasshi; 1978 Dec; 75(12):1972-82. PubMed ID: 84084
    [No Abstract]   [Full Text] [Related]  

  • 52. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Glycoprotein metabolism in galactosamine-induced hepatitis].
    Reutter W; Keppler D; Lesch R; Decker K
    Verh Dtsch Ges Inn Med; 1969; 75():363-5. PubMed ID: 5400154
    [No Abstract]   [Full Text] [Related]  

  • 54. An antibody to neutrophils attenuates alpha-naphthylisothiocyanate-induced liver injury.
    Dahm LJ; Schultze AE; Roth RA
    J Pharmacol Exp Ther; 1991 Jan; 256(1):412-20. PubMed ID: 1846424
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [On the molecular mechanism of action of (+)-cyanidanol-3 (author's transl)].
    Hennings G
    Arzneimittelforschung; 1979; 29(5):720-4. PubMed ID: 387044
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic studies of trimethadione and its metabolite in rats with chemical-induced liver injury.
    Tanaka E; Kinoshita H; Yamamoto T; Kuroiwa Y; Takabatake E
    J Pharmacobiodyn; 1981 Aug; 4(8):576-83. PubMed ID: 7299621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Aggravation of acute galactosamine hepatitis by a sodic bicarbonated water in rats (author's transl)].
    de La Tour J; Souchard M; Chariot J; Rozé C; Potet F; Vaille C
    J Pharmacol; 1981; 12(1):37-50. PubMed ID: 6261045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The influence of chronic lobular hepatitis on pharmacokinetics of cefoperazone--a novel galactose single-point method as a measure of residual liver function.
    Hu OY; Tang HS; Chang CL
    Biopharm Drug Dispos; 1994 Oct; 15(7):563-76. PubMed ID: 7849232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of D-galactosamine upon the NAD-metabolism in rat liver.
    Kröger H; Grätz R; Grahn H
    Int J Biochem; 1983; 15(9):1131-6. PubMed ID: 6311640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ultrastructural features in galactosamine-induced hepatitis.
    Medline A; Schaffner F; Popper H
    Exp Mol Pathol; 1970 Apr; 12(2):201-11. PubMed ID: 4907704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.